Barin Nastaran, Balcioglu Hayri E, de Heer Iris, de Wit Maurice, Lamfers Martine L M, van Royen Martin E, French Pim J, Accardo Angelo
Department of Precision and Microsystems Engineering, Delft University of Technology, Mekelweg 2, Delft, 2628 CD, The Netherlands.
Department of Neurology, Erasmus MC Cancer Institute, University Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands.
Small. 2022 Dec;18(49):e2204485. doi: 10.1002/smll.202204485. Epub 2022 Oct 7.
A major obstacle in glioma research is the lack of in vitro models that can retain cellular features of glioma cells in vivo. To overcome this limitation, a 3D-engineered scaffold, fabricated by two-photon polymerization, is developed as a cell culture model system to study patient-derived glioma cells. Scanning electron microscopy, (live cell) confocal microscopy, and immunohistochemistry are employed to assess the 3D model with respect to scaffold colonization, cellular morphology, and epidermal growth factor receptor localization. Both glioma patient-derived cells and established cell lines successfully colonize the scaffolds. Compared to conventional 2D cell cultures, the 3D-engineered scaffolds more closely resemble in vivo glioma cellular features and allow better monitoring of individual cells, cellular protrusions, and intracellular trafficking. Furthermore, less random cell motility and increased stability of cellular networks is observed for cells cultured on the scaffolds. The 3D-engineered glioma scaffolds therefore represent a promising tool for studying brain cancer mechanobiology as well as for drug screening studies.
神经胶质瘤研究中的一个主要障碍是缺乏能够在体外保留神经胶质瘤细胞体内细胞特征的模型。为了克服这一局限性,通过双光子聚合制造的三维工程支架被开发为一种细胞培养模型系统,用于研究患者来源的神经胶质瘤细胞。利用扫描电子显微镜、(活细胞)共聚焦显微镜和免疫组织化学来评估三维模型的支架定植、细胞形态和表皮生长因子受体定位情况。神经胶质瘤患者来源的细胞和已建立的细胞系都成功地在支架上定植。与传统的二维细胞培养相比,三维工程支架更接近体内神经胶质瘤细胞特征,并且能够更好地监测单个细胞、细胞突起和细胞内运输。此外,在支架上培养的细胞随机细胞运动性较低,细胞网络稳定性增强。因此,三维工程神经胶质瘤支架是研究脑癌力学生物学以及药物筛选研究的一个有前景的工具。
Biochem Biophys Res Commun. 2018-4-15
ACS Appl Mater Interfaces. 2021-2-24
Zhonghua Zhong Liu Za Zhi. 2015-10
Adv Healthc Mater. 2025-5
ACS Appl Mater Interfaces. 2025-1-29
Front Bioeng Biotechnol. 2024-2-16
Front Bioeng Biotechnol. 2023-3-9